首页 > 最新文献

AACE Clinical Case Reports最新文献

英文 中文
Unmasking a Rare Genetic Mutation: The Importance of Genetic Testing in Refractory Hypertriglyceridemia. 揭开罕见基因突变的面纱:基因检测对难治性高甘油三酯血症的重要性
Q3 Medicine Pub Date : 2024-08-22 eCollection Date: 2024-11-01 DOI: 10.1016/j.aace.2024.08.006
Panagiotis Theodoropoulos, Nina Maria Fanaropoulou, Anastasios Manessis

Background/objective: Genetic causes of hypertriglyceridemia like familial chylomicronemia syndrome can be overlooked in everyday practice. We report a patient with a rare genetic mutation, highlighting the importance of genetic testing for timely diagnosis and prevention of complications.

Case report: A 45-year-old Hispanic female presented with serum triglyceride levels of 749 mg/dL, refractory to rosuvastatin 10 mg daily and omega-3 ethyl esters 2 g daily. Initial studies showed total cholesterol of 278 mg/dL and high-density lipoprotein of 38 mg/dL. Physical examination was negative for hepatosplenomegaly and xanthoma, with no reported history of acute pancreatitis. Despite treatment escalation with gemfibrozil, fenofibrate, and icosapent ethyl, her triglyceride levels remained elevated, peaking at 4300 mg/dL. Seven years after presentation, genetic testing revealed homozygosity for c.11delC of the apolipoprotein A5 gene, confirming the diagnosis of familial chylomicronemia syndrome. Postdiagnosis, the patient adhered to a strict low-fat diet with daily fat intake of less than 15-20 g, limited simple sugars, refined carbohydrates, and alcohol, leading to a nadir of serum triglycerides of 197 mg/dL.

Discussion: The identified mutation is exceedingly rare (<0.01%), as most associated mutations involve the lipoprotein lipase gene. There are no approved therapies for genetic hypertriglyceridemia. The mainstay of treatment is a very low-fat diet to prevent complications.

Conclusion: We underscore the importance of genetic testing in refractory hypertriglyceridemia despite a lack of clinical signs. A definitive diagnosis can alleviate patient burden, improve therapeutic adherence, and enhance the patient-physician relationship.

背景/目的:高甘油三酯血症如家族性乳糜低血症综合征的遗传原因在日常实践中可能被忽视。我们报告一个罕见基因突变的病人,强调基因检测对及时诊断和预防并发症的重要性。病例报告:一名45岁的西班牙裔女性,血清甘油三酯水平为749 mg/dL,每日瑞舒伐他汀10 mg和每日欧米伽-3乙酯2 g难治。初步研究显示总胆固醇为278毫克/分升,高密度脂蛋白为38毫克/分升。体格检查为肝脾肿大和黄瘤阴性,无急性胰腺炎病史报告。尽管使用吉非罗齐、非诺贝特和二十戊二烯乙酯治疗,她的甘油三酯水平仍然升高,峰值为4300 mg/dL。7年后,基因检测显示载脂蛋白A5基因c.11delC纯合子,确诊为家族性乳糜微粒血症综合征。诊断后,患者坚持严格的低脂饮食,每日脂肪摄入量低于15-20 g,限制单糖、精制碳水化合物和酒精,导致血清甘油三酯最低为197 mg/dL。结论:尽管缺乏临床症状,我们强调在难治性高甘油三酯血症中进行基因检测的重要性。明确的诊断可以减轻患者负担,提高治疗依从性,并加强医患关系。
{"title":"Unmasking a Rare Genetic Mutation: The Importance of Genetic Testing in Refractory Hypertriglyceridemia.","authors":"Panagiotis Theodoropoulos, Nina Maria Fanaropoulou, Anastasios Manessis","doi":"10.1016/j.aace.2024.08.006","DOIUrl":"10.1016/j.aace.2024.08.006","url":null,"abstract":"<p><strong>Background/objective: </strong>Genetic causes of hypertriglyceridemia like familial chylomicronemia syndrome can be overlooked in everyday practice. We report a patient with a rare genetic mutation, highlighting the importance of genetic testing for timely diagnosis and prevention of complications.</p><p><strong>Case report: </strong>A 45-year-old Hispanic female presented with serum triglyceride levels of 749 mg/dL, refractory to rosuvastatin 10 mg daily and omega-3 ethyl esters 2 g daily. Initial studies showed total cholesterol of 278 mg/dL and high-density lipoprotein of 38 mg/dL. Physical examination was negative for hepatosplenomegaly and xanthoma, with no reported history of acute pancreatitis. Despite treatment escalation with gemfibrozil, fenofibrate, and icosapent ethyl, her triglyceride levels remained elevated, peaking at 4300 mg/dL. Seven years after presentation, genetic testing revealed homozygosity for c.11delC of the apolipoprotein A5 gene, confirming the diagnosis of familial chylomicronemia syndrome. Postdiagnosis, the patient adhered to a strict low-fat diet with daily fat intake of less than 15-20 g, limited simple sugars, refined carbohydrates, and alcohol, leading to a nadir of serum triglycerides of 197 mg/dL.</p><p><strong>Discussion: </strong>The identified mutation is exceedingly rare (<0.01%), as most associated mutations involve the lipoprotein lipase gene. There are no approved therapies for genetic hypertriglyceridemia. The mainstay of treatment is a very low-fat diet to prevent complications.</p><p><strong>Conclusion: </strong>We underscore the importance of genetic testing in refractory hypertriglyceridemia despite a lack of clinical signs. A definitive diagnosis can alleviate patient burden, improve therapeutic adherence, and enhance the patient-physician relationship.</p>","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"10 6","pages":"240-243"},"PeriodicalIF":0.0,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11680754/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Panhypopituitarism Secondary to Pituitary Abscess. 继发于垂体脓肿的全垂体功能减退症。
Q3 Medicine Pub Date : 2024-08-21 eCollection Date: 2024-11-01 DOI: 10.1016/j.aace.2024.08.004
Samir S E Ahmed, Mona Vahidi Rad, Sydney Westphal
{"title":"Panhypopituitarism Secondary to Pituitary Abscess.","authors":"Samir S E Ahmed, Mona Vahidi Rad, Sydney Westphal","doi":"10.1016/j.aace.2024.08.004","DOIUrl":"https://doi.org/10.1016/j.aace.2024.08.004","url":null,"abstract":"","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"10 6","pages":"264-265"},"PeriodicalIF":0.0,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11680748/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iodine Deficiency Hypothyroidism Among Children in the United States - 21st Century Resurgence? 美国儿童缺碘甲状腺功能减退症--21 世纪的回潮?
Q3 Medicine Pub Date : 2024-08-14 eCollection Date: 2024-11-01 DOI: 10.1016/j.aace.2024.08.003
Sujatha Seetharaman, Sabitha Sasidharan Pillai, Avani Ganta, Kate Millington, Jose Bernardo Quintos, Lisa Swartz Topor, Monica Serrano-Gonzalez

Background/objective: Iodine deficiency hypothyroidism is an important cause of neurocognitive and motor impairment in children globally. In the United States, universal salt iodization, which began in the 1920s, led to a dramatic decline in iodine deficiency hypothyroidism. However, iodine deficiency may be reemerging due to increased consumption of noniodized salts, decreased dairy iodine concentrations, and decreased intake of iodine containing foods due to food allergies, dietary preferences such as vegan diets, or restrictive food intake disorders.

Case report: We present a case series that challenges the existing clinical paradigm for hypothyroidism and describe 3 patients without underlying thyroid dysfunction who were diagnosed with iodine deficiency hypothyroidism over an 18-month period beginning in February 2021 in Northeastern United States. Prior studies reported 2 additional cases diagnosed in that same time frame at our clinical center.

Discussion: We report significant heterogeneity in clinical presentation: 3 patients had large goiters, 1 had a mild goiter, and 1 patient had no goiter. Biochemical tests were also variable and included a wide range of thyroid stimulating hormone elevations.

Conclusion: We suggest that a spot urine iodine concentration, combined with an elevated serum thyroglobulin level, can be an alternative to a 24-hour urinary iodine excretion for the diagnosis of iodine deficiency hypothyroidism given the clinical challenges of obtaining the latter. Thyroid function normalized in all patients with iodine supplementation.

背景/目的:碘缺乏性甲状腺功能减退症是全球儿童神经认知和运动障碍的重要病因。在美国,始于20世纪20年代的普遍食盐加碘,导致了碘缺乏症甲状腺功能减退症的急剧下降。然而,由于非碘盐摄入增加、乳制品碘浓度降低、食物过敏、饮食偏好(如纯素饮食)或限制性食物摄入障碍导致含碘食物摄入减少,碘缺乏可能再次出现。病例报告:我们提出了一个病例系列,挑战了现有的甲状腺功能减退的临床范例,并描述了3例无潜在甲状腺功能障碍的患者,从2021年2月开始,在美国东北部的18个月期间被诊断为碘缺乏性甲状腺功能减退。先前的研究报告了在我们临床中心同一时间段诊断的另外2例病例。讨论:我们报告了临床表现的显著异质性:3例患者有大甲状腺肿,1例有轻度甲状腺肿,1例无甲状腺肿。生化测试也不同,包括大范围的促甲状腺激素升高。结论:考虑到诊断缺碘性甲状腺功能减退的临床难度,我们建议尿碘浓度与血清甲状腺球蛋白水平升高相结合,可作为24小时尿碘排泄的替代方法。所有补充碘的患者甲状腺功能恢复正常。
{"title":"Iodine Deficiency Hypothyroidism Among Children in the United States - 21st Century Resurgence?","authors":"Sujatha Seetharaman, Sabitha Sasidharan Pillai, Avani Ganta, Kate Millington, Jose Bernardo Quintos, Lisa Swartz Topor, Monica Serrano-Gonzalez","doi":"10.1016/j.aace.2024.08.003","DOIUrl":"10.1016/j.aace.2024.08.003","url":null,"abstract":"<p><strong>Background/objective: </strong>Iodine deficiency hypothyroidism is an important cause of neurocognitive and motor impairment in children globally. In the United States, universal salt iodization, which began in the 1920s, led to a dramatic decline in iodine deficiency hypothyroidism. However, iodine deficiency may be reemerging due to increased consumption of noniodized salts, decreased dairy iodine concentrations, and decreased intake of iodine containing foods due to food allergies, dietary preferences such as vegan diets, or restrictive food intake disorders.</p><p><strong>Case report: </strong>We present a case series that challenges the existing clinical paradigm for hypothyroidism and describe 3 patients without underlying thyroid dysfunction who were diagnosed with iodine deficiency hypothyroidism over an 18-month period beginning in February 2021 in Northeastern United States. Prior studies reported 2 additional cases diagnosed in that same time frame at our clinical center.</p><p><strong>Discussion: </strong>We report significant heterogeneity in clinical presentation: 3 patients had large goiters, 1 had a mild goiter, and 1 patient had no goiter. Biochemical tests were also variable and included a wide range of thyroid stimulating hormone elevations.</p><p><strong>Conclusion: </strong>We suggest that a spot urine iodine concentration, combined with an elevated serum thyroglobulin level, can be an alternative to a 24-hour urinary iodine excretion for the diagnosis of iodine deficiency hypothyroidism given the clinical challenges of obtaining the latter. Thyroid function normalized in all patients with iodine supplementation.</p>","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"10 6","pages":"236-239"},"PeriodicalIF":0.0,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11680746/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Ectopic Adrenocorticotropic Hormone Syndrome Due to Pulmonary Carcinoid Tumor: A Case Report and Literature Review. 肺类癌所致严重异位促肾上腺皮质激素综合征1例并文献复习。
Q3 Medicine Pub Date : 2024-08-13 eCollection Date: 2024-11-01 DOI: 10.1016/j.aace.2024.08.002
Karissa Aldrete, Leena Shahla

Background/objective: Pulmonary carcinoid tumors are a rare cause of Cushing's syndrome and usually present with an indolent course. Here, we present a case of rapid onset and severe Cushing's syndrome due to a typical pulmonary carcinoid tumor.

Case report: A 32-year-old woman developed diabetes, hypertension, and weight gain of 50 pounds over 3 months. Laboratory evaluation was significant for elevated cortisol and adrenocorticotropic hormone levels and levels were nonsuppressible on low and high-dose dexamethasone suppression tests. Chest computed tomography revealed a pulmonary nodule and biopsy showed a typical carcinoid tumor. She was treated with steroidogenesis inhibitors with a plan for surgical excision but developed worsening complications of hypercortisolemia. She eventually underwent cryoablation of the tumor, but unfortunately passed away just 6 months after her initial presentation.

Discussion: Cushing's syndrome in typical pulmonary carcinoid tumors is rarely seen and usually presents with mild hypercortisolism similar to Cushing's disease. Severe hypercortisolemia from typical pulmonary carcinoid tumors can represent a more aggressive pathology or metastatic disease. Severe Cushing's syndrome is associated with significant morbidity and mortality and requires rapid tumor localization as surgical resection can be curative.

Conclusion: This case highlights a rare presentation of severe Cushing's syndrome due to a typical pulmonary carcinoid.

背景/目的:肺类癌是引起库欣综合征的罕见原因,通常表现为惰性病程。在此,我们报告一例由典型的肺类癌肿瘤引起的快速发作和严重的库欣综合征。病例报告:一名32岁女性患有糖尿病、高血压,3个月内体重增加50磅。实验室评估显示皮质醇和促肾上腺皮质激素水平升高,低剂量和高剂量地塞米松抑制试验水平不受抑制。胸部电脑断层显示一肺结节,活组织检查显示典型的类癌。她接受类固醇生成抑制剂治疗,并计划手术切除,但高皮质醇血症并发症恶化。她最终接受了肿瘤的冷冻消融,但不幸的是,在她最初的表现后仅6个月就去世了。讨论:库欣综合征在典型的肺类癌肿瘤中罕见,通常表现为与库欣病相似的轻度高皮质醇血症。典型肺类癌引起的严重高糖血症可能是一种更具侵袭性的病理或转移性疾病。严重的库欣综合征具有显著的发病率和死亡率,需要快速定位肿瘤,因为手术切除可以治愈。结论:本病例是一例罕见的由典型的肺类癌引起的严重库欣综合征。
{"title":"Severe Ectopic Adrenocorticotropic Hormone Syndrome Due to Pulmonary Carcinoid Tumor: A Case Report and Literature Review.","authors":"Karissa Aldrete, Leena Shahla","doi":"10.1016/j.aace.2024.08.002","DOIUrl":"10.1016/j.aace.2024.08.002","url":null,"abstract":"<p><strong>Background/objective: </strong>Pulmonary carcinoid tumors are a rare cause of Cushing's syndrome and usually present with an indolent course. Here, we present a case of rapid onset and severe Cushing's syndrome due to a typical pulmonary carcinoid tumor.</p><p><strong>Case report: </strong>A 32-year-old woman developed diabetes, hypertension, and weight gain of 50 pounds over 3 months. Laboratory evaluation was significant for elevated cortisol and adrenocorticotropic hormone levels and levels were nonsuppressible on low and high-dose dexamethasone suppression tests. Chest computed tomography revealed a pulmonary nodule and biopsy showed a typical carcinoid tumor. She was treated with steroidogenesis inhibitors with a plan for surgical excision but developed worsening complications of hypercortisolemia. She eventually underwent cryoablation of the tumor, but unfortunately passed away just 6 months after her initial presentation.</p><p><strong>Discussion: </strong>Cushing's syndrome in typical pulmonary carcinoid tumors is rarely seen and usually presents with mild hypercortisolism similar to Cushing's disease. Severe hypercortisolemia from typical pulmonary carcinoid tumors can represent a more aggressive pathology or metastatic disease. Severe Cushing's syndrome is associated with significant morbidity and mortality and requires rapid tumor localization as surgical resection can be curative.</p><p><strong>Conclusion: </strong>This case highlights a rare presentation of severe Cushing's syndrome due to a typical pulmonary carcinoid.</p>","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"10 6","pages":"232-235"},"PeriodicalIF":0.0,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11680749/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endocrine Care of a 19-year-old Woman With Isolated Hypogonadotropic Hypogonadism due to 4H Syndrome. 一名因 4H 综合征导致孤立性腺功能减退的 19 岁女性的内分泌护理。
Q3 Medicine Pub Date : 2024-08-10 eCollection Date: 2024-11-01 DOI: 10.1016/j.aace.2024.08.001
Bright Nwatamole, Sumana Kundu, God-Dowell O Odukudu, Prava Basnet, Lubna Mirza

Background/objective: 4H syndrome is a rare form of leukodystrophy characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism. In 95% of cases, hypomyelination is present, but other clinical features, such as hypodontia and hypogonadotropic hypogonadism, are not always present and may not be necessary for diagnosis. Hypogonadotropic hypogonadism is the most common endocrine complication that can occur in 4H syndrome. Other endocrine abnormalities are short stature and growth hormone deficiency.

Case report: We present a 19-year-old female with 4H syndrome due to POLR3B gene mutations who presented with primary amenorrhea. She was referred to our endocrinology clinic by her primary care physician. She was diagnosed with 4H syndrome at age 15 by her pediatrician when she initially presented with primary amenorrhea, ataxia, and tremors and underwent karyotyping and confirmatory genetic tests. However, she received no endocrine care before coming to our clinic at 19. Neurologic exam revealed slight tremors in outstretched hands. A brain MRI study revealed no intracranial abnormalities. We subsequently placed her on Loestrin birth control, an estrogen/progestin combination contraceptive, and she begun having her menstrual periods.

Discussion: The prevalence of POLR3-related leukodystrophy is currently unknown. It can appear during childhood or later in life. Early onset increases the risk of mortality in young adulthood. Endocrine care entails hormone replacement therapy and monitoring for dysfunction over time.

Conclusion: Early diagnosis of hypogonadotropic hypogonadism in women, with or without other hormonal deficiencies caused by 4H syndrome, is crucial for effective treatment. Treatment should be multidisciplinary and aimed mainly at correcting low estrogen levels.

背景/目的:4H综合征是一种罕见的脑白质营养不良,其特征为髓鞘增生减少、牙髓缺损和促性腺功能减退。在95%的病例中,存在髓鞘增生减退,但其他临床特征,如髓鞘减退和促性腺功能减退,并不总是存在,可能不是诊断所必需的。促性腺功能减退是4H综合征中最常见的内分泌并发症。其他内分泌异常包括身材矮小和生长激素缺乏。病例报告:我们报告一名19岁的女性,因POLR3B基因突变而患有4H综合征,并表现为原发性闭经。她是由她的初级保健医生转介到我们内分泌科诊所的。她在15岁时被儿科医生诊断为4H综合征,当时她最初表现为原发性闭经、共济失调和震颤,并进行了核型和确认性基因检测。然而,她在19岁来我们诊所之前没有接受过内分泌治疗。神经系统检查显示伸出的双手有轻微震颤。脑部核磁共振检查未发现颅内异常。随后,我们给她使用了Loestrin节育,这是一种雌激素/黄体酮联合避孕药,她开始有了月经。讨论:polr3相关脑白质营养不良的患病率目前尚不清楚。它可以出现在童年或以后的生活中。早发会增加青年期死亡的风险。内分泌护理包括激素替代疗法和监测功能障碍随着时间的推移。结论:早期诊断妇女促性腺功能减退,伴或不伴4H综合征引起的其他激素缺乏,对有效治疗至关重要。治疗应该是多学科的,主要针对纠正低雌激素水平。
{"title":"Endocrine Care of a 19-year-old Woman With Isolated Hypogonadotropic Hypogonadism due to 4H Syndrome.","authors":"Bright Nwatamole, Sumana Kundu, God-Dowell O Odukudu, Prava Basnet, Lubna Mirza","doi":"10.1016/j.aace.2024.08.001","DOIUrl":"10.1016/j.aace.2024.08.001","url":null,"abstract":"<p><strong>Background/objective: </strong>4H syndrome is a rare form of leukodystrophy characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism. In 95% of cases, hypomyelination is present, but other clinical features, such as hypodontia and hypogonadotropic hypogonadism, are not always present and may not be necessary for diagnosis. Hypogonadotropic hypogonadism is the most common endocrine complication that can occur in 4H syndrome. Other endocrine abnormalities are short stature and growth hormone deficiency.</p><p><strong>Case report: </strong>We present a 19-year-old female with 4H syndrome due to POLR3B gene mutations who presented with primary amenorrhea. She was referred to our endocrinology clinic by her primary care physician. She was diagnosed with 4H syndrome at age 15 by her pediatrician when she initially presented with primary amenorrhea, ataxia, and tremors and underwent karyotyping and confirmatory genetic tests. However, she received no endocrine care before coming to our clinic at 19. Neurologic exam revealed slight tremors in outstretched hands. A brain MRI study revealed no intracranial abnormalities. We subsequently placed her on Loestrin birth control, an estrogen/progestin combination contraceptive, and she begun having her menstrual periods.</p><p><strong>Discussion: </strong>The prevalence of POLR3-related leukodystrophy is currently unknown. It can appear during childhood or later in life. Early onset increases the risk of mortality in young adulthood. Endocrine care entails hormone replacement therapy and monitoring for dysfunction over time.</p><p><strong>Conclusion: </strong>Early diagnosis of hypogonadotropic hypogonadism in women, with or without other hormonal deficiencies caused by 4H syndrome, is crucial for effective treatment. Treatment should be multidisciplinary and aimed mainly at correcting low estrogen levels.</p>","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"10 6","pages":"229-231"},"PeriodicalIF":0.0,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11680756/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetic Ketoacidosis Without Diabetes Mellitus in Acute Pancreatitis. 急性胰腺炎合并糖尿病酮症酸中毒。
Q3 Medicine Pub Date : 2024-07-29 eCollection Date: 2024-11-01 DOI: 10.1016/j.aace.2024.07.007
Duha Zaffar, Aditi Rawat, Robert T Chow, Kashif M Munir

Background/objective: Diabetic ketoacidosis (DKA) is typically but not exclusively seen in patients with a history of diabetes mellitus.

Case report: This is a case of 39 year-old male who was diagnosed with acute pancreatitis based on characteristic symptoms and positive CT findings on presentation. Laboratory testing revealed elevated serum glucose 251 mg/dL, low serum bicarbonate 8 mmol/L, increased anion gap 21, and elevated serum beta-hydroxybutyrate 9.62 mmol/L. Diagnosis of DKA was made, however patient did not carry a diagnosis of diabetes mellitus. His hemoglobin A1c in hospital was normal at 5.4%. Additionally, follow-up hemoglobin A1c at 4 months and 10 months postdischarge did not imply diabetes mellitus, 5.8% at both time points. The patient who was initially managed with intravenous insulin required no insulin or oral diabetic medication on discharge. All these findings argued against new onset diabetes mellitus.

Discussion: This case explores the potential pathophysiology that underlies this phenomenon including possible transient insulin insufficiency due to beta cell dysfunction from pancreatic inflammation. It also highlights the reversibility and transiency of possible beta cell dysfunction during acute pancreatitis and emphasizes the importance of closely assessing the patients' insulin requirements upon discharge, especially when a prior history of diabetes mellitus is absent.

Conclusion: DKA can occur as a rare complication of acute pancreatitis in a nondiabetic patient. Hyperglycemia associated with acute pancreatitis-induced DKA can be temporary and these patients might not necessarily require insulin upon discharge. Therefore, careful discharge planning is very important in such patients.

背景/目的:糖尿病酮症酸中毒(DKA)通常发生在有糖尿病史的患者身上,但并非唯一:这是一个 39 岁男性的病例,根据其特征性症状和就诊时的 CT 阳性结果,他被诊断为急性胰腺炎。实验室检查显示血清葡萄糖升高 251 mg/dL,血清碳酸氢盐偏低 8 mmol/L,阴离子间隙增加 21,血清 beta-hydroxybutyrate 升高 9.62 mmol/L。诊断结果为 DKA,但患者没有糖尿病诊断。住院期间,他的血红蛋白 A1c 正常,为 5.4%。此外,出院后 4 个月和 10 个月的随访血红蛋白 A1c 均为 5.8%,并不意味着患者患有糖尿病。最初使用静脉注射胰岛素的患者在出院时不需要胰岛素或口服糖尿病药物。所有这些结果都表明,该患者没有新发糖尿病:本病例探讨了这一现象的潜在病理生理学基础,包括胰腺炎症引起的β细胞功能障碍可能导致的一过性胰岛素分泌不足。该病例还强调了急性胰腺炎期间可能出现的β细胞功能障碍的可逆性和短暂性,并强调出院时密切评估患者胰岛素需求的重要性,尤其是在既往无糖尿病史的情况下:结论:DKA 是非糖尿病患者急性胰腺炎的罕见并发症。急性胰腺炎诱发的 DKA 相关高血糖可能是暂时的,这些患者出院时不一定需要胰岛素。因此,为这类患者制定谨慎的出院计划非常重要。
{"title":"Diabetic Ketoacidosis Without Diabetes Mellitus in Acute Pancreatitis.","authors":"Duha Zaffar, Aditi Rawat, Robert T Chow, Kashif M Munir","doi":"10.1016/j.aace.2024.07.007","DOIUrl":"10.1016/j.aace.2024.07.007","url":null,"abstract":"<p><strong>Background/objective: </strong>Diabetic ketoacidosis (DKA) is typically but not exclusively seen in patients with a history of diabetes mellitus.</p><p><strong>Case report: </strong>This is a case of 39 year-old male who was diagnosed with acute pancreatitis based on characteristic symptoms and positive CT findings on presentation. Laboratory testing revealed elevated serum glucose 251 mg/dL, low serum bicarbonate 8 mmol/L, increased anion gap 21, and elevated serum beta-hydroxybutyrate 9.62 mmol/L. Diagnosis of DKA was made, however patient did not carry a diagnosis of diabetes mellitus. His hemoglobin A1c in hospital was normal at 5.4%. Additionally, follow-up hemoglobin A1c at 4 months and 10 months postdischarge did not imply diabetes mellitus, 5.8% at both time points. The patient who was initially managed with intravenous insulin required no insulin or oral diabetic medication on discharge. All these findings argued against new onset diabetes mellitus.</p><p><strong>Discussion: </strong>This case explores the potential pathophysiology that underlies this phenomenon including possible transient insulin insufficiency due to beta cell dysfunction from pancreatic inflammation. It also highlights the reversibility and transiency of possible beta cell dysfunction during acute pancreatitis and emphasizes the importance of closely assessing the patients' insulin requirements upon discharge, especially when a prior history of diabetes mellitus is absent.</p><p><strong>Conclusion: </strong>DKA can occur as a rare complication of acute pancreatitis in a nondiabetic patient. Hyperglycemia associated with acute pancreatitis-induced DKA can be temporary and these patients might not necessarily require insulin upon discharge. Therefore, careful discharge planning is very important in such patients.</p>","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"10 6","pages":"220-223"},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11680747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parathyroid Hormone–Related Peptide Secretion From a Pancreatic Neuroendocrine Tumor: A Rare Case Report of Severe Hypercalcemia 胰腺神经内分泌肿瘤分泌甲状旁腺激素相关肽。严重高钙血症的罕见病例报告。
Q3 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.aace.2024.04.009
Erin Foley MBBS, Prashanth Hari Dass MBBS, Esther O’Sullivan MBBS, PhD

Background/Objective

Hypercalcemia is a common occurrence associated with malignancy, due to a number of causes: (1) lytic bone metastases, (2) production of 1,25-dihydroxyvitamin D from lymphoma, and (3) parathyroid hormone–related peptide (PTHrP) secretion usually from solid tumors.

Case Report

A 56-year-old woman presented with symptoms of severe hypercalcemia. Investigations determined that this was due to PTHrP secretion from a pancreatic neuroendocrine tumor (pNET), a noted complication in 1.1% of pNET cases. Although unfit for curative therapy, the patient was treated with fluid replacement, bisphosphonates, calcitonin, and denosumab. After treatment, she had recurrent severe symptomatic hypercalcemia on several occasions despite adjunctive therapy with a somatostatin analog. Ultimately, the patient died as a result of refractory hypercalcemia.

Discussion

The hypercalcemia that is rarely associated with PTHrP secretion from pNETs is aggressive and often refractory to the usual medical treatment of hypercalcemia of malignancy. Effective treatment requires cytoreduction of the causative tumor. Denosumab, a receptor activator of nuclear factor kappa beta ligand inhibitor, has proven useful in some cases.

Conclusion

This challenging case highlighted the rare but potentially fatal association of pNET with hypercalcemia. Hypercalcemia was the main cause of mortality in an otherwise relatively indolent malignancy.

背景/目的高钙血症是一种常见的恶性肿瘤并发症,其原因有很多:(1)淋巴瘤骨转移;(2)淋巴瘤产生 1,25-二羟维生素 D;(3)甲状旁腺激素相关肽(PTHrP)分泌,通常来自实体瘤。经检查确定,这是由于胰腺神经内分泌肿瘤(pNET)分泌 PTHrP 所致。虽然不适合接受根治性治疗,但患者接受了液体补充、双磷酸盐、降钙素和地诺单抗治疗。治疗后,尽管使用了体生长抑素类似物辅助治疗,她仍多次反复出现严重的症状性高钙血症。讨论pNET分泌的PTHrP很少伴有高钙血症,这种高钙血症具有侵袭性,通常对恶性肿瘤高钙血症的常规药物治疗无效。有效的治疗需要对致病肿瘤进行细胞减灭术。在某些病例中,核因子卡巴受体激活剂β配体抑制剂地诺单抗(Denosumab)被证明是有用的。高钙血症是导致这种相对不严重的恶性肿瘤死亡的主要原因。
{"title":"Parathyroid Hormone–Related Peptide Secretion From a Pancreatic Neuroendocrine Tumor: A Rare Case Report of Severe Hypercalcemia","authors":"Erin Foley MBBS,&nbsp;Prashanth Hari Dass MBBS,&nbsp;Esther O’Sullivan MBBS, PhD","doi":"10.1016/j.aace.2024.04.009","DOIUrl":"10.1016/j.aace.2024.04.009","url":null,"abstract":"<div><h3>Background/Objective</h3><p>Hypercalcemia is a common occurrence associated with malignancy, due to a number of causes: (1) lytic bone metastases, (2) production of 1,25-dihydroxyvitamin D from lymphoma, and (3) parathyroid hormone–related peptide (PTHrP) secretion usually from solid tumors.</p></div><div><h3>Case Report</h3><p>A 56-year-old woman presented with symptoms of severe hypercalcemia. Investigations determined that this was due to PTHrP secretion from a pancreatic neuroendocrine tumor (pNET), a noted complication in 1.1% of pNET cases. Although unfit for curative therapy, the patient was treated with fluid replacement, bisphosphonates, calcitonin, and denosumab. After treatment, she had recurrent severe symptomatic hypercalcemia on several occasions despite adjunctive therapy with a somatostatin analog. Ultimately, the patient died as a result of refractory hypercalcemia.</p></div><div><h3>Discussion</h3><p>The hypercalcemia that is rarely associated with PTHrP secretion from pNETs is aggressive and often refractory to the usual medical treatment of hypercalcemia of malignancy. Effective treatment requires cytoreduction of the causative tumor. Denosumab, a receptor activator of nuclear factor kappa beta ligand inhibitor, has proven useful in some cases.</p></div><div><h3>Conclusion</h3><p>This challenging case highlighted the rare but potentially fatal association of pNET with hypercalcemia. Hypercalcemia was the main cause of mortality in an otherwise relatively indolent malignancy.</p></div>","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"10 4","pages":"Pages 160-163"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2376060524000452/pdfft?md5=11bef7d4a927d87d5ab8aa84546b1854&pid=1-s2.0-S2376060524000452-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141041108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unusual Case of Adrenal Artery Aneurysm: Diagnosis and Management 肾上腺动脉瘤的罕见病例--诊断与治疗
Q3 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.aace.2024.03.004
Omolade O. Sogade MD , C. Corbin Frye MD , Daniel Picus MD , Sina Jasim MD, MPH , Taylor C. Brown MD, MHS
{"title":"Unusual Case of Adrenal Artery Aneurysm: Diagnosis and Management","authors":"Omolade O. Sogade MD ,&nbsp;C. Corbin Frye MD ,&nbsp;Daniel Picus MD ,&nbsp;Sina Jasim MD, MPH ,&nbsp;Taylor C. Brown MD, MHS","doi":"10.1016/j.aace.2024.03.004","DOIUrl":"10.1016/j.aace.2024.03.004","url":null,"abstract":"","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"10 4","pages":"Pages 166-167"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2376060524000282/pdfft?md5=7945ae337bb1fd37a29a302f18d21cd7&pid=1-s2.0-S2376060524000282-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140279024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Dysglycemia in a Pregnancy Complicated by Fanconi-Bickel Syndrome 范康尼-比克尔综合征并发妊娠血糖异常的处理方法
Q3 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.aace.2024.07.008
Emily D. Szmuilowicz, Ellen Fruzyna, Nigel Madden, Janelle R. Bolden, Anne Kozek, E. Vucko, Cybele Ghossein, Grant Barish
{"title":"Management of Dysglycemia in a Pregnancy Complicated by Fanconi-Bickel Syndrome","authors":"Emily D. Szmuilowicz, Ellen Fruzyna, Nigel Madden, Janelle R. Bolden, Anne Kozek, E. Vucko, Cybele Ghossein, Grant Barish","doi":"10.1016/j.aace.2024.07.008","DOIUrl":"https://doi.org/10.1016/j.aace.2024.07.008","url":null,"abstract":"","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"13 s1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141842614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypocalcemia and Hypoparathyroidism Associated With Critical Illness and Aplastic Anemia 与危重病和再生障碍性贫血有关的低钙血症和甲状旁腺功能减退症
Q3 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.aace.2024.04.007
Tatiana Tselovalnikova MD, PhD , Kavita Jadhav MD, FACP , John Foxworth PharmD , Peminda K. Cabandugama MD, DABOM , Sophia Galustian MD , Betty M. Drees MD, FACP, FACE

Background/Objective

Severe hypocalcemia is common in critically ill patients. There are different mechanisms. To our knowledge, there are no data about the acute presentation of hypocalcemia at the time of diagnosis of aplastic anemia (AA). The objective of this case report was to describe the case of hypoparathyroidism with severe hypocalcemia in a critically ill patient with AA.

Case Report

A 60-year-old man presented with severe hypocalcemia with a calcium level of 6.1 mg/dL (reference range, 8.6-10.3 mg/dL) and hypoparathyroidism with a parathyroid hormone level of 11 pg/mL (reference range, 12-88 pg/mL). He developed a critical state caused by newly diagnosed AA and its complications, such as an acute decrease in the platelet value to a critically low level of 2 × 103/cmm, complicated by neutropenic fever and lower gastrointestinal bleeding. After the initiation of immunosuppressive therapy for AA, his parathyroid hormone-calcium metabolism improved and remained stable but did not normalize completely.

Discussion

In our patient, hypoparathyroidism with hypocalcemia may have been caused by cytokine-related upregulation of the calcium-sensing receptor in the setting of AA. On the other hand, given the severity of the initial hypocalcemia and only partial improvement in calcium homeostasis with residual mild hypocalcemia after treatment initiation for AA, autoimmune causes cannot be entirely ruled out, nor could a combination of cytokine-mediated and autoimmune causes.

Conclusion

It is essential to treat the underlying causes of hypocalcemia, which, in this case, were AA and hypoparathyroidism.

背景/目的严重低钙血症在重症患者中很常见。其发病机制各不相同。据我们所知,目前还没有关于再生障碍性贫血(AA)诊断时出现急性低钙血症的数据。病例报告一名60岁的男性患者出现严重低钙血症,血钙水平为6.1毫克/分升(参考范围:8.6-10.3毫克/分升),甲状旁腺功能减退,甲状旁腺激素水平为11皮克/毫升(参考范围:12-88皮克/毫升)。新确诊的 AA 及其并发症导致他病情危重,如血小板值急剧下降至 2 × 103/cmm 的极低水平,并伴有中性粒细胞减少性发热和下消化道出血。在开始对AA进行免疫抑制治疗后,他的甲状旁腺激素-钙代谢情况有所改善并保持稳定,但并未完全恢复正常。另一方面,鉴于最初低钙血症的严重程度,以及在开始治疗AA后,钙稳态仅得到部分改善,但仍存在轻度低钙血症,因此不能完全排除自身免疫原因,也不能排除细胞因子介导的原因和自身免疫原因的结合。
{"title":"Hypocalcemia and Hypoparathyroidism Associated With Critical Illness and Aplastic Anemia","authors":"Tatiana Tselovalnikova MD, PhD ,&nbsp;Kavita Jadhav MD, FACP ,&nbsp;John Foxworth PharmD ,&nbsp;Peminda K. Cabandugama MD, DABOM ,&nbsp;Sophia Galustian MD ,&nbsp;Betty M. Drees MD, FACP, FACE","doi":"10.1016/j.aace.2024.04.007","DOIUrl":"10.1016/j.aace.2024.04.007","url":null,"abstract":"<div><h3>Background/Objective</h3><p>Severe hypocalcemia is common in critically ill patients. There are different mechanisms. To our knowledge, there are no data about the acute presentation of hypocalcemia at the time of diagnosis of aplastic anemia (AA). The objective of this case report was to describe the case of hypoparathyroidism with severe hypocalcemia in a critically ill patient with AA.</p></div><div><h3>Case Report</h3><p>A 60-year-old man presented with severe hypocalcemia with a calcium level of 6.1 mg/dL (reference range, 8.6-10.3 mg/dL) and hypoparathyroidism with a parathyroid hormone level of 11 pg/mL (reference range, 12-88 pg/mL). He developed a critical state caused by newly diagnosed AA and its complications, such as an acute decrease in the platelet value to a critically low level of 2 × 10<sup>3</sup>/cmm, complicated by neutropenic fever and lower gastrointestinal bleeding. After the initiation of immunosuppressive therapy for AA, his parathyroid hormone-calcium metabolism improved and remained stable but did not normalize completely.</p></div><div><h3>Discussion</h3><p>In our patient, hypoparathyroidism with hypocalcemia may have been caused by cytokine-related upregulation of the calcium-sensing receptor in the setting of AA. On the other hand, given the severity of the initial hypocalcemia and only partial improvement in calcium homeostasis with residual mild hypocalcemia after treatment initiation for AA, autoimmune causes cannot be entirely ruled out, nor could a combination of cytokine-mediated and autoimmune causes.</p></div><div><h3>Conclusion</h3><p>It is essential to treat the underlying causes of hypocalcemia, which, in this case, were AA and hypoparathyroidism.</p></div>","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"10 4","pages":"Pages 156-159"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2376060524000427/pdfft?md5=32b9107dd91bea878fad51273bc7fe8f&pid=1-s2.0-S2376060524000427-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141042665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
AACE Clinical Case Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1